Top compounds associated with response to KMT2D

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Topotecan	CTRPv2	pan-cancer	AAC	0.15	3e-05
mRNA	navitoclax:birinapant (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.17	3e-05
mRNA	ceranib-2	CTRPv2	pan-cancer	AAC	0.15	5e-05
mRNA	indisulam	CTRPv2	pan-cancer	AAC	0.14	5e-05
mRNA	BRD-K28456706	CTRPv2	pan-cancer	AAC	0.16	5e-05
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.15	6e-05
mRNA	GMX-1778	CTRPv2	pan-cancer	AAC	0.16	7e-05
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.15	7e-05
mRNA	necrosulfonamide	CTRPv2	pan-cancer	AAC	0.17	8e-05
mRNA	Gemcitabine	CTRPv2	pan-cancer	AAC	0.14	8e-05

Download CSV